Unlike arginine vasopressin, the selective V 1a receptor agonist FE 202158 does not cause procoagulant effects by releasing von Willebrand factor

Critical Care Medicine

Volumn 40, Issue 6, 2012, Pages 1957-1960

  Rehberg, Sebastian ^a,b   Enkhbaatar, Perenlei ^a   Rehberg, Janina ^a   La, Erin ^c   Ferdyan, Nicky ^c   Qi, Steve ^c   Wisniewski, Kazimierz ^c   Traber, Lillian D ^a   Schteingart, Claudio D ^c   Rivière, Pierre J M ^c   Laporte, Régent ^c   Traber, Daniel L ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c Ferring Pharmaceuticals AS   (Denmark)

Author keywords

blood coagulation; peptide hormones; vasopressin V 1a receptor; vasopressin V 2 receptor; vasopressor; von Willebrand factor

Indexed keywords

ARGIPRESSIN; DESMOPRESSIN; FE 202158; HEMOGLOBIN; PROCOAGULANT; SODIUM CHLORIDE; UNCLASSIFIED DRUG; VASOPRESSIN; VASOPRESSIN V1A RECEPTOR; VASOPRESSIN V2 RECEPTOR; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY HEMODYNAMICS; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; SEPTIC SHOCK;

ANIMALS; ARGININE VASOPRESSIN; BLOOD COAGULATION; FEMALE; PROSPECTIVE STUDIES; RANDOM ALLOCATION; RECEPTORS, VASOPRESSIN; SHEEP; SHOCK, SEPTIC; VASOPRESSINS; VON WILLEBRAND FACTOR;

EID: 84861532392     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31824e0fe5     Document Type: Article

References (10)

1. Dellinger RP, Levy MM, Carlet JM, et al; International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296-327
2. Kaufmann JE, Vischer UM: Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP). J Thromb Haemost 2003; 1:682-689
3. Claus RA, Bockmeyer CL, Budde U, et al: Variations in the ratio between von Willebrand factor and its cleaving protease during systemic inflammation and association with severity and prognosis of organ failure. Thromb Haemost 2009; 101:239-247
4. Kayal S, Jaïs JP, Aguini N, et al: Elevated circulating E-selectin, intercellular adhesion molecule 1, and von Willebrand factor in patients with severe infection. Am J Respir Crit Care Med 1998; 157(3 Pt 1):776-784
5. Laporte R, Kohan A, Heitzmann J, et al: Pharmacological characterization of FE 202158, a novel, potent, selective, and short-acting peptidic vasopressin V1a receptor full agonist for the treatment of vasodilatory hypotension. J Pharmacol Exp Ther 2011; 337:786-796
6. Traber DL: Selective V1a receptor agonists in experimental septic shock [Abstract]. Crit Care 2007; 11(Suppl 4):P51
7. Russell JA, Walley KR, Singer J, et al; VASST Investigators: Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008; 358:877-887
8. Neuenschwander S, Pliska V: Effects of neurohypophyseal hormone analogues on blood clotting factor VIII and fibrinolytic activity in sheep. Eur J Pharmacol 1997; 323:205-213
9. Patel KN, Soubra SH, Bellera RV, et al: Differential role of von Willebrand factor and P-selectin on microvascular thrombosis in endotoxemia. Arterioscler Thromb Vasc Biol 2008; 28:2225-2230
10. Rehberg S, Ertmer C, Vincent JL, et al: Role of selective V1a receptor agonism in ovine septic shock. Crit Care Med 2011; 39:119-125